Estellis is designed for use by females of reproductive age to serve as an oral contraceptive, effectively preventing pregnancy.
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Estellis is a combination oral contraceptive (COC) containing:
Pediatric Use: Estellis is approved for females of reproductive age. However, it is not intended for use before the first menstrual cycle (menarche).
Geriatric Use: It is not indicated for postmenopausal women.
Days 1-24: Take one pink active tablet at the same time each day.
Days 25-28: Take one white inactive tablet daily for four days.
If one pink active tablet is missed: Take the missed tablet as soon as possible, even if it means taking two tablets in one day. Continue with the remaining tablets as per schedule.
If two or more pink active tablets are missed (Week 1 or Week 2): Take one of the missed tablets immediately, followed by the scheduled tablet for the current day (this means taking two tablets on that day). The remaining missed tablets should be discarded. Continue taking one tablet per day until the pack is finished. Use additional non-hormonal contraception for the next 7 days.
If two pink active tablets are missed in Week 3: Take one missed tablet immediately, followed by the scheduled tablet for the current day. Discard any other missed tablets. Complete the active tablets and skip the inactive tablets. Start a new pack the next day. Additional contraception should be used for 7 days.
If an inactive (white) tablet is missed: Skip the missed tablet and continue taking one tablet per day until the pack is finished.
CYP3A Inducers (e.g., certain antibiotics, antifungal agents, and anticonvulsants): These may reduce the effectiveness of Estellis by increasing the metabolism of its active ingredients, leading to breakthrough bleeding or contraceptive failure. Avoid concurrent use or ensure additional contraceptive measures for up to 28 days after stopping the CYP3A inducer.
Overdose symptoms may include nausea, vomiting, severe headaches, or unusual vaginal bleeding. In rare cases, overdose-related thromboembolic events (blood clots) may occur.
Pediatric accidental ingestion has been reported to cause nausea, drowsiness, or vaginal bleeding. Monitor potassium, sodium, and acid-base balance. In high-risk patients, short-term preventive anticoagulation therapy may be required.
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.